Pascal and Francis Bibliographic Databases



Selection :

Permanent link

A phase II open-label study of DHA-paclitaxel (Taxoprexin) by 2-h intravenous infusion in previously untreated patients with locally advanced or metastatic gastric or oesophageal adenocarcinoma

JONES, Robert J1 ; HAWKINS, Robert E2 ; EATOCK, Martin M3 ; FERRY, David R4 ; ESKENS, Ferry A. L. M5 ; WILKE, Hansjochen6 ; JEFFRY EVANS, T. R1
[1] Centre for Oncology and Applied Pharmacology, Beatson Oncology Centre, Western Infirmary, University of Glasgow, Dumbarton Road, Glasgow G11 6NT, United Kingdom
[2] Paterson Institute for Cancer Research, Christie Hospital, Wilmslow Road, Manchester M20 4BX, United Kingdom
[3] Belfast City Hospital, Lisbum Road, Belfast BT9 7AB, United Kingdom
[4] Deanasly Centre, New Cross Hospital, Wolverhampton WV10 OQP, United Kingdom
[5] Department of Medical Oncology, Erasmus University Medical Centre, PO Box 2040, 3000 CA Rotterdam, Netherlands
[6] Internal Oncology/Hematology, Kliniken-Essen-Mitte, Henricistrasse 92, Essen 45136, Germany

Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 3, pp 435-441, 7 p ; ref : 27 ref

Scientific domain
Medical oncology; Pharmacology drugs
Springer, Berlin
Publication country
Document type
Author keyword
Adenocarcinoma, DHA-paclitaxel Oesophagus Stomach
Keyword (fr)
Adénocarcinome de l'estomac Adénocarcinome de l'oesophage Anticancéreux Cancer de l'estomac Cancer de l'oesophage Estomac Homme Métastase Oesophage Paclitaxel Perfusion Stade avancé Système H-2 Voie intraveineuse Adénocarcinome estomac Adénocarcinome oesophage Stade localement avancé Antimitotique Appareil digestif Cancer Dérivé du taxane Pathologie de l'appareil digestif Pathologie de l'estomac Pathologie de l'oesophage Tumeur maligne
Keyword (en)
Stomach adenocarcinoma Esophagus adenocarcinoma Antineoplastic agent Stomach cancer Esophagus cancer Stomach Human Metastasis Esophagus Paclitaxel Perfusion Advanced stage H-2-System Intravenous administration Stomach adenocarcinoma Esophagus adenocarcinoma Locally advanced stage Antimitotic Digestive system Cancer Taxane derivatives Digestive diseases Gastric disease Esophageal disease Malignant tumor
Keyword (es)
Adenocarcinoma de estómago Adenocarcinoma de esófago Anticanceroso Cáncer del estómago Cáncer del esófago Estómago Hombre Metástasis Esófago Paclitaxel Perfusión Estadio avanzado Sistema H-2 Vía intravenosa Adenocarcinoma estómago Adenocarcinoma esófago Estadio localmente avanzado Antimitótico Aparato digestivo Cáncer Taxane derivado Aparato digestivo patología Estómago patología Esófago patología Tumor maligno
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents

002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13A Esophagus / 002B13A01 Tumors

002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13B Stomach. Duodenum. Small intestine. Colon. Rectum. Anus / 002B13B01 Tumors

Gastroenterology. Liver. Pancreas. Abdomen Pharmacological treatments
INIST identifier

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web